From 2008.igem.org
(Difference between revisions)
|
|
| Line 1: |
Line 1: |
| - | {{Paris/Menu}}
| + | delete |
| - | | + | |
| - | = First Model =
| + | |
| - | | + | |
| - | [[Image:Synchro1.jpg|500px|center]]
| + | |
| - | | + | |
| - | Strain : double mutant ΔflhDC and ΔflgM
| + | |
| - | | + | |
| - | Designed plasmids
| + | |
| - | <center>
| + | |
| - | {| border="1"
| + | |
| - | |align="center"|Generic Name
| + | |
| - | |align="center"|Construction
| + | |
| - | |align="center"|Advancement
| + | |
| - | |-
| + | |
| - | |align="center"|FlhDC
| + | |
| - | |align="center"|pTet - FlhDC
| + | |
| - | |align="center"|☣
| + | |
| - | |-
| + | |
| - | |align="center"|AHL enzyme
| + | |
| - | |align="center"|pFlhB - LasI
| + | |
| - | |align="center"|☣
| + | |
| - | |-
| + | |
| - | |align="center"|AHL Receptor
| + | |
| - | |align="center"|pConstitutive - LasR
| + | |
| - | |align="center"|☣
| + | |
| - | |-
| + | |
| - | |align="center"|FlhDC Inhibitor
| + | |
| - | |align="center"|pLas - TetR - GFP
| + | |
| - | |align="center"|☣
| + | |
| - | |}
| + | |
| - | </center>
| + | |
| - | | + | |
| - | = Second Model =
| + | |
| - | | + | |
| - | | + | |
| - | | + | |
| - | [[Image:Synchro2.jpg|500px|center]]
| + | |
| - | | + | |
| - | | + | |
| - | Strain : mutant ΔflgM
| + | |
| - | | + | |
| - | Designed plasmids
| + | |
| - | <center>
| + | |
| - | {| border="1"
| + | |
| - | |align="center"|Generic Name
| + | |
| - | |align="center"|Construction
| + | |
| - | |align="center"|Advancement
| + | |
| - | |-
| + | |
| - | |align="center"|Reporter
| + | |
| - | |align="center"|pFlhB - LasI
| + | |
| - | |align="center"|☣
| + | |
| - | |-
| + | |
| - | |align="center"|AHL Receptor
| + | |
| - | |align="center"|pConstitutive - LasR
| + | |
| - | |align="center"|☣
| + | |
| - | |-
| + | |
| - | |align="center"|FlhDC Inhibitor
| + | |
| - | |align="center"|pLas - OmpR - GFP
| + | |
| - | |align="center"|☣
| + | |
| - | |}
| + | |
| - | </center>
| + | |
Latest revision as of 11:05, 28 August 2008
delete
"
